key: cord-0733250-ishegebe
authors: Sang, Charlie Joseph; Heindl, Brittain; Von Mering, Gregory; Brott, Brigitta; Kopf, Robert S.; Benson, Paul V.; Rajapreyar, Indranee
title: Stress Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Co-Infection
date: 2020-06-09
journal: JACC Case Rep
DOI: 10.1016/j.jaccas.2020.05.068
sha: 964f4826ed45e0b69a8c96053ddf71ad77bc628a
doc_id: 733250
cord_uid: ishegebe

Abstract Myocardial injury is associated with excess mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections, but the mechanisms of injury are diverse. We describe a case of stress induced cardiomyopathy in the setting of SARS-CoV-2 and Influenza A coinfection.

Myocardial injury is associated with excess mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections, but the mechanisms of injury are diverse. We describe a case of stress induced cardiomyopathy in the setting of SARS-CoV-2 and Influenza A coinfection.

A 58-year-old female with rheumatoid arthritis, interstitial lung disease, chronic obstructive pulmonary disease, and hypertension presented with fever and respiratory distress. A viral respiratory panel confirmed influenza virus type A H1-2009. Electrocardiogram showed loss of anterior septal forces (Figure 1, Panel A) . High-sensitivity troponin I (hs-Troponin I) level was 9 ng/L (0-14 ng/L), and brain natriuretic peptide was 13 pg/mL (0-100 pg/mL). Chest X-ray revealed bronchiectasis with interstitial thickening. SARS-CoV-2 reverse-transcriptasepolymerase-chain-reaction (RT-PCR) assay was positive. Broad spectrum antibiotics and oseltamivir were initiated. She had progressive hypoxemia and hypotension requiring intubation. She developed supraventricular tachycardia with a heart rate above 200 bpm. She became pulseless and was successfully resuscitated. Two hours later she had a second episode; sinus rhythm was restored with adenosine, and an amiodarone infusion was started. Subsequent Sections of the coronary arteries did not show pathologic abnormality. The right ventricle showed myocyte hypertrophy and normal for age intramyocardial adipose tissue.

Cardiovascular comorbidities are associated with higher rates of myocardial injury and more severe disease in COVID-19 (1). Our patient was diagnosed with stress induced cardiomyopathy based on echocardiogram findings of diffuse apical hypokinesis. Though this patient had risk factors for atherosclerotic coronary disease, it is unknown if she had heart failure on admission, and other common etiologies were not explored. Histopathologic examination of the heart showed changes associated with chronic hypertensive and atherosclerotic disease; however, in the absence of coronary pathology at autopsy, we can consider a non-ischemic etiology. Based on the focal areas of interstitial fibrosis with mononuclear cells, there may have been intrinsic myocyte damage by the virus or global inflammatory deterioration. She may have also experienced true catecholamine excess with the stress of respiratory failure.

The impact of influenza co-infection must also be considered, as this virus is known to contribute to cardiovascular morbidity and mortality due to upregulation of the inflammatory response and endothelial dysfunction (2) . As such, Influenza A likely had significant effects on her cardiac functioning. Co-infection with SARS-CoV-2 is of great concern, with limited data delineating the prevalence of this phenomena (3) , and positive viral panels should not provide reassurance against co-infection. 

Panel A and B revealing myocyte hypertrophy with interstitial fibrosis. Panel C exhibits interstitial fibrosis, focal myocyte hypertrophy, and presence of lymphocytes and plasma cells.

Apical views with and without Definity® contrast. Transthoracic echocardiogram revealed a severely reduced left ventricular ejection fraction with disproportionate apical hypokinesis consistent with stress induced cardiomyopathy.

Abnormal ECGs are common in patients with COVID-19

Clinicians must maintain awareness of cardiomyopathies associated with SARS-CoV-2

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Potential Effects of Coronaviruses on the Cardiovascular System: A Review

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens